CytomX Therapeutics, Inc. (CTMX)
NASDAQ: CTMX · Real-Time Price · USD
3.330
+0.050 (1.52%)
At close: Oct 7, 2025, 4:00 PM EDT
3.280
-0.050 (-1.50%)
After-hours: Oct 7, 2025, 6:39 PM EDT
CytomX Therapeutics Market Cap
CytomX Therapeutics has a market cap or net worth of $549.16 million as of October 7, 2025. Its market cap has increased by 500.83% in one year.
Market Cap
549.16M
Enterprise Value
397.96M
1-Year Change
500.83%
Ranking
Category
Stock Price
$3.33
Market Cap Chart
Since October 8, 2015, CytomX Therapeutics's market cap has increased from $464.70M to $549.16M, an increase of 18.18%. That is a compound annual growth rate of 1.68%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 6, 2025 | 540.90M | 571.09% |
| Dec 31, 2024 | 80.60M | -22.35% |
| Dec 29, 2023 | 103.80M | -1.80% |
| Dec 30, 2022 | 105.70M | -62.58% |
| Dec 31, 2021 | 282.50M | -6.70% |
| Dec 31, 2020 | 302.80M | -19.81% |
| Dec 31, 2019 | 377.60M | -44.44% |
| Dec 31, 2018 | 679.60M | -16.18% |
| Dec 29, 2017 | 810.80M | 102.65% |
| Dec 30, 2016 | 400.10M | -46.78% |
| Dec 31, 2015 | 751.80M | 61.78% |
| Oct 8, 2015 | 464.70M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 753.98B |
| Johnson & Johnson | 454.31B |
| AbbVie | 413.22B |
| UnitedHealth Group | 326.22B |
| Novo Nordisk | 264.73B |
| AstraZeneca | 264.35B |
| Novartis AG | 256.18B |
| Abbott Laboratories | 234.25B |